科兴制药(688136.SH)筹划发行H股股票并在香港联交所上市

Core Viewpoint - The company, Sinovac Biotech Ltd. (科兴制药), aims to enhance its strategic layout of "innovation + internationalization" by accelerating overseas business development and improving its overall competitiveness and international brand image through the issuance of H-shares and listing on the Hong Kong Stock Exchange [1] Group 1 - The company plans to issue H-shares to optimize its capital structure [1] - The move is intended to leverage the advantages of international capital markets for diversified financing channels [1] - The initiative is part of the company's strategy to deepen its presence in the global market [1]